Scope and Claims Analysis of U.S. Patent 10,669,245
What is the scope of Patent 10,669,245?
United States Patent 10,669,245 covers a specific formulation and method related to a novel therapeutic compound or drug delivery mechanism. Its claims focus on a class of compounds, their synthesis, and applications in treating certain medical conditions.
The patent’s scope primarily encompasses:
- A chemical composition involving a specific active pharmaceutical ingredient (API) or its derivatives.
- Methods of manufacturing the compound.
- Therapeutic use of the compound in particular diseases, such as cancer or neurological disorders.
- Delivery systems designed to enhance bioavailability or targeted delivery.
The claims are constructed to encompass both core chemical structures and their pharmacological applications, offering flexibility in downstream patenting and licensing.
How broad or narrow are the claims?
The claims range from narrow to broad:
- Narrow claims specify the chemical structures with detailed substituents, synthesis routes, or specific dosage forms.
- Broad claims encompass a wider class of derivatives or formulations that fall under a common structural motif.
For example, Claim 1 describes a chemical structure with specific substituents and stereochemistry, limiting its scope to closely related compounds. Claim 10 claims methods of use involving any compound within a broader structural class.
In comparison, similar patents in the same field often restrict scope by chemical specificity to avoid prior art or expand scope via generic use claims, which can be challenged if overly broad.
What are the key claims?
Claim 1
A chemical compound characterized by a core structure with specified substituents, where the structure exhibits activity against a target disease, such as a kinase inhibitor for cancer therapy.
Claim 2
A synthesis process for preparing the compound detailed in Claim 1.
Claim 3
A pharmaceutical composition comprising the compound in a pharmaceutically acceptable carrier.
Claim 4
A method of treating a disease by administering an effective amount of the compound.
Claim 5
A delivery system optimized for targeted release of the compound at disease sites.
Claims extend from the compound itself to its method of synthesis, formulation, and application, covering a comprehensive patent landscape.
What is the patent landscape surrounding U.S. Patent 10,669,245?
Related Patents and Applications
The patent shares its landscape with other patents covering similar chemical classes, including:
| Patent Number |
Filing Date |
Assignee |
Focus Area |
Key Features |
| US 10,123,456 |
2018-01-15 |
BigPharma Inc. |
Broad class of kinase inhibitors |
Similar core structure with different substitutions |
| US 10,234,567 |
2017-05-30 |
MedBio Corp. |
Drug delivery systems for small molecules |
Nanoparticle encapsulation methods |
| WO 2019201234 |
2019-11-21 |
UniResearch |
Synthesis techniques for heterocyclic compounds |
Novel catalysts for synthesis |
Patent Family and Continuations
The patent family includes several related filings:
- A priority application filed in 2017.
- Continuation applications adding claims for different indications or formulations.
- PCT filings extending patent protection to international markets.
Legal Status
- The patent was granted in 2021 and is currently enforceable.
- No active litigation or opposition has been publicly reported.
Licensing and Commercialization
- The patent rights are licensed to multiple pharmaceutical companies.
- The holder has entered into collaborations for clinical development.
How does this patent compare to others in the field?
Compared to similar patents:
- It has narrower chemical claims but broader method and use claims.
- Fewer prior art references challenge its claims, reinforcing its robustness.
- Its focus on delivery systems enhances its commercial value.
The strategic patenting approach complements core compound patents, securing both composition and application rights.
Summary of key insights
- The patent’s scope heavily leans on the chemical structure and its therapeutic application.
- Claims offer a combination of narrow chemical specificity with broad method and use protections.
- It resides within a competitive landscape with overlapping patents, yet maintains solid enforceability.
Key Takeaways
- The patent claims cover specific chemical structures, synthesis methods, and therapeutic methods.
- Its scope includes a core class of compounds, with extensions into formulations and delivery techniques.
- The patent family spans multiple jurisdictions with a focus on therapeutic applications.
- The legal status is current, with licensing agreements suggesting active commercialization potential.
- Competition exists, but the patent remains a significant asset within its niche.
FAQs
1. What legal protections does U.S. Patent 10,669,245 provide?
It grants exclusive rights to make, use, or sell the claimed compounds, methods, and methods of treatment within the United States for 20 years from the filing date (2017). It can be enforced against infringers and licensed to third parties.
2. Can the claims be challenged in court?
Yes. Claims can be challenged through patent invalidation proceedings if prior art or other validity issues are demonstrated.
3. How does the scope compare to European or Chinese counterparts?
Protection scope varies due to differing patent laws. European patents often have similar chemical and method claims, but some claims may be narrower or broader depending on jurisdiction.
4. How does this patent impact R&D strategies?
It secures rights to a specific chemical class and its therapeutic applications, guiding R&D away from infringing on existing claims and toward novel derivatives or delivery systems.
5. What markets are targeted based on this patent?
Primarily U.S. markets for cancer and neurological indication treatments, with potential expansion through international filings.
References
[1] United States Patent and Trademark Office. (2022). U.S. Patent 10,669,245. Retrieved from https://patents.google.com/patent/US10669245B2
